2002年南京市医疗机构第一次药品集中招标采购分析与思考  

Analysis of First Concentrate Bid of Nanjing Hospital in 2002

作　　者：张骠[1] 谈瑄忠[1] 

机构地区：[1]南京中医药大学第三附属医院,南京210001

出　　处：《中国卫生经济》2006年第10期51-53,共3页Chinese Health Economics

基　　金：南京市医学重点发展项目(ZKX0219)

摘　　要：目的:通过对药品招标的分析,呼吁建立完善的药品价格管理体系和规范医疗行为。方法:对2002年南京市医疗机构第一次药品集中招标采购情况进行分类分析。结果:本次抗微生物和寄生虫类招标药品降价幅度为29%,国产药品降价幅度大于进口和合资药品。结论:应注意同规格和不同规格招标药品价格关系的合理性,我国药品生产企业应加强自主产品的研发。Objective： Appeal to built a standard administer system of the price and standard the medical treatment. through the analysis of medicine concentrate bid. Methods： Analysis the range of concentrate bid of Nanjing Hospital in 2002. Results： The price of the bidding medicine of anti-infection this time reduced by 29%, and the price of medicine made in China reduced lower than that of import and joint investment. Conclusion： We should be attention to the relation of prices between the different standard. The enterprise of inland should enforce the explosion of new production.

关 键 词：招标 价格分析 定价 规范用药 

分 类 号：R95[医药卫生—药学]